Synergy Biomedical Announces Expanded FDA Clearance Of BIOSPHERE PUTTY For Spine Indications

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

COLLEGEVILLE, Pa.--(BUSINESS WIRE)--Synergy Biomedical, LLC, a developer of novel biomaterial products, announced today that it has received 510(k) clearance from the US Food and Drug Administration to market BIOSPHERE® PUTTY as a bone graft extender for use in the posterolateral spine.

Help employers find you! Check out all the jobs and post your resume.

Back to news